abstract |
The present invention generally relates to a novel catalytic subunit of a lipid kinase designated p110 delta . Polynucleotides encoding p110 delta and recombinant p110 delta polypeptides are provided along with antibodies to p110 delta , assays for identifying inhibitors of p110 delta , and the like. |